What is the Current Share Price of Beta Drugs Ltd?
- Answer Field
-
Beta Drugs Ltd share price is for NSE ₹ 1,750.00 & for BSE ₹ 0.00 as on Jul 09 2025 03:24 PM.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, BETA DRUGS LIMITED share price is currently at ₹ 1750, which is down by ₹ -23.65 from its previous closing. Today, the stock has fluctuated between ₹ 1750.00 and ₹ 1793.00. Over the past year, BETA DRUGS LIMITED has achieved a return of 54.33 %. In the last month alone, the return has been -1.65 %. Read More...
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.37 | 32.19 | 1.99 | 278.72 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 161.00 | 20.15 | 1.61 | 1697.67 | 105.05 / 184.95 |
CIPLA LTD | 1488.15 | 23.36 | 3.85 | 120199.04 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 339.30 | 12.99 | 2.75 | 998.59 | 189.00 / 449.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.37 | 93.26 | 5.74 | 278.72 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 709.65 | 40.37 | 6.28 | 2051.64 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 9136.70 | 130.49 | 29.65 | 22841.75 | 6222.35 / 10653.05 |
BLISS GVS PHARMA LTD | 161.00 | 24.62 | 1.60 | 1697.67 | 105.05 / 184.95 |
Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017
Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.
The company is primarily engaged in the manufacturing of oncology products. The Company's products range from anti-cancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease.
The Company set up the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new 'state of the art' manufacturing facility for oncology formulations in 2014; developed in-house Albumin bound Paclitaxel in 2015; started in-house API Plant - Adley Labs in 2017.
In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores.
The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB; launched 1st Indian Brand of Dasatinib, BEEDAN. In 2021, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.
Beta Drugs Ltd share price is for NSE ₹ 1,750.00 & for BSE ₹ 0.00 as on Jul 09 2025 03:24 PM.
The market cap of Beta Drugs Ltd for NSE ₹ 1,682.41 & for BSE ₹ 0.00 as on Jul 09 2025 03:24 PM.
The 52 Week High and Low of Beta Drugs Ltd for NSE is ₹ 2,215.24 and ₹ 1,121.90 and for BSE is ₹ 0.00 and ₹ 0.00.
The 1 year returns on the stock has been 54.33%.
As on Jul 09 2025 03:24 PM the price-to-earnings (PE) ratio for Beta Drugs Ltd share is 116.00.
As on Jul 09 2025 03:24 PM, the price-to-book (PB) ratio for Beta Drugs Ltd share is 127.82.
You can trade in Beta Drugs Ltd shares with Bajaj Broking by opening a demat account.
To buy Beta Drugs Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Beta Drugs Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found